National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes

scientific article published on 23 March 2007

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1373/CLINCHEM.2006.084715
P698PubMed publication ID17384000

P50authorMauro PanteghiniQ56418921
Jorge Ordonez-LlanosQ68816021
Alan B. StorrowQ88008602
P2093author name stringChristopher P Cannon
David A Morrow
L Kristin Newby
Robert H Christenson
Robert L Jesse
Fred S Apple
National Academy of Clinical Biochemistry
Allan S Jaffe
Alan H B Wu
Jan Ravkilde
Gary Francis
Johannes Mair
Franca Pagani
Wilson Tang
Jillian Tate
IFCC Comittee on Standardization of Markers of Cardiac Damege
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectacute coronary syndromeQ266018
P304page(s)547-551
P577publication date2007-03-23
P1433published inClinical ChemistryQ849687
P1476titleNational Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes
P478volume53

Reverse relations

cites work (P2860)
Q3558819710,000-fold concentration increase in proteins in a cascade microchip using anionic ITP by a 3-D numerical simulation with experimental results
Q3578616510,000-fold concentration increase of the biomarker cardiac troponin I in a reducing union microfluidic chip using cationic isotachophoresis
Q222419222014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Q40160496An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.
Q85167019Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population
Q34747362Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome
Q42373682Association Between Troponin Levels and Embolic Stroke of Undetermined Source
Q43612169Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance.
Q82338927Comparison of conventional and highly-sensitive troponin I measurement in ultra-marathon runners
Q34680828Detection of cardiac biomarkers using single polyaniline nanowire-based conductometric biosensors
Q47275584Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction.
Q53450274Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I
Q36367690Elective minimally invasive coronary artery bypass: shunt or tournique occlusion? Assessment of a protective role of perioperative left anterior descending shunting on myocardial damage. A prospective randomized study
Q34771430Evaluation in an emergency department of rapid separator tubes containing thrombin for serum preparation prior to hs-cTnT and CK-MB analyses
Q51837358Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
Q84538472High sensitivity troponin in chest pain and acute coronary syndromes. A step forward?
Q36974321High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice?
Q37722773High-sensitivity cardiac troponins in everyday clinical practice
Q37040319Measurement of cardiac troponins to detect myocardial infarction using high-sensitivity assays: South African guidelines.
Q50936392Performance characteristics of loci method for measuring cardiac troponin I on the dimension EXL.
Q51838993Quality Improvement Intervention for Reduction of Redundant Testing.
Q37155277Recent Advances in Point-of-Care Diagnostics for Cardiac Markers
Q35332734Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination
Q58733510Sex differences in ischemic heart disease and heart failure biomarkers
Q26749044Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists
Q38140759The evolving role of cardiac troponin in the evaluation of cardiac disorders
Q37508526The importance of having a flexible scope ISO 15189 accreditation and quality specifications based on biological variation--the case of validation of the biochemistry analyzer Dimension Vista.
Q37129419The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome
Q38209902Universal MI definition update for cardiovascular disease

Search more.